ID   Karyochi-XX-3
AC   CVCL_E2UL
SY   Karyochi-XX.3
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of FP0-Agr-Neo cell line was transferred into the the cytoplasm of the FP1.0 cell line (from parent cell line).
CC   Doubling time: 30-32 hours (Patent=US8859278).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UI ! Karyochi-XX
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
RX   Patent=US8859278;
RA   Trakht I., Kalantarov G.F.;
RT   "Fully human hybridoma fusion partner cell lines.";
RL   Patent number US8859278, 14-Oct-2014.
//